Angiogenesis in Chronic Inflammatory Liver Disease

Hepatology

Volumn 39, Issue 5, 2004, Pages 1185-1195

  Medina, Jesús ^a   Arroyo, Alicia G ^a   Sánchez Madrid, Francisco ^a   Moreno Otero, Ricardo ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANGIOSTATIN; ANTITHROMBIN III; BETA INTERFERON; CADHERIN; CD31 ANTIGEN; CLAUDIN; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GAP JUNCTION PROTEIN; INTEGRIN; OCCLUDIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SCATTER FACTOR; THROMBOCYTE FACTOR 4; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CHRONIC INFLAMMATION; CHRONIC INFLAMMATORY LIVER DISEASE; CHRONIC LIVER DISEASE; HUMAN; LIVER BLOOD FLOW; LIVER DISEASE; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER REGENERATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; VIRUS HEPATITIS;

ANIMALS; HEPATITIS, CHRONIC; HUMANS; LIVER; NEOVASCULARIZATION, PATHOLOGIC;

EID: 2342637066     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20193     Document Type: Short Survey

References (118)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
3. Pugh CW, Ratcliffe P. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677-684.
4. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101:2567-2578.
5. Hiraoka N, Allen E, Apel I, Gyetko M, Weiss S. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998;95:365-377.
6. Jackson C. Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens 2002;11:295-299.
7. Hynes RO. A reevaluation of integrins as mediators of angiogenesis. Nat Med 2002;8:918-921.
8. Bajou K, Noel A, Gerard R, Masson V, Brunner N, Holst-Hansen C, et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 1998;4:923-928.
9. Galvez BG, Matias-Roman S, Albar J, Sanchez-Madrid F, Arroyo A. Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 2001;276:37491-37500.
10. Galvez BG, Matias-Roman S, Yanez-Mo M, Sanchez-Madrid F, Arroyo A. ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 2002;159:509-521.
11. Luttun A, Dewerchin M, Collen D, Carmeliet P. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Curr Atheroscler Rep 2000;2:407-416.
12. Sugiura T, Berditchevski F. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 1999;146:1375-1389.
13. Penas PF, Garcia-Diez A, Sanchez-Madrid F, Yanez-Mo M. Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol 2000;114:1126-1135.
14. Ferrara N, Gerber H, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
15. Mould AW, Tonks I, Cahill M, Pettit A, Thomas R, Hayward N, et al. VEGF-B gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum 2003;48:2660-2669.
16. Silvestre JS, Tamarat R, Ebrahimian T, Le-Roux A, Clergue M, Emmanuel F, et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 2003;93:114-123.
17. Yancopoulos GD, Davis S, Gale N, Rudge J, Wiegand S, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
18. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001;2:95-101.
19. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, et al. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003;273:83-101.
20. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3:422-433.
21. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-693.
22. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001;153:543-553.
23. Thurston G, Rudge J, Ioffe E, Zhou H, Ross L, Croll S, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-463.
24. Carlson TR, Feng Y, Maisonpierre P, Mrksich M, Morla A. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 2001;276:26516-26525.
25. Visconti RP, Richardson C, Sato T. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 2002;99:8219-8224.
26. Maisonpierre PC, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
27. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, Dijke Pt. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002;21:1743-1753.
28. McCuskey RS, Reilly F. Hepatic microvasculature: dynamic structure and its regulation. Sem Liver Dis 1993;13:1-12.
29. Camenisch G, Pisabarro M, Sherman D, Kowalski J, Nagel M, Hass P, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 2002;227:17281-17290.
30. Fausto N, Laird A, Webber E. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995;9:1527-1536.
31. Michalopoulos GK, DeFrances M. Liver regeneration. Science 1997;276:60-66.
32. Fausto N. Liver regeneration. J Hepatol 2000;32:19-31.
33. Stolz DB, Ross M, Salem H, Mars W, Michalopoulos G, Enomoto K. Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. Am J Pathol 1999;155:1487-1498.
34. Wack KE, Ross M, Zegarra V, Sysko L, Watkins S, Stolz D. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. HEPATOLOGY 2001;33:363-378.
35. Ross MA, Sander C, Kleeb T, Watkins S, Stolz D. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. HEPATOLOGY 2001;34:1135-1148.
36. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001;49:121-130.
37. Sato T, El-Assal O, Ono T, Yamanoi A, Dhar D, Nagasue N. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 2001;34:690-698.
38. Drixler TA, Vogten M, Ritchie E, Vroonhoven Tv, Gebbink M, Voest E, et al. Liver regeneration is an angiogenesis-associated phenomenon. Ann Surg 2002;236:703-711.
39. Gerlach C, Sakkab D, Scholzen T, Dassler R, Alison M. Ki-67 expression during rat liver regeneration after partial hepatectomy. HEPATOLOGY 1997;26:573-578.
40. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996;226:176-179.
41. Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683-689.
42. LeCouter J, Moritz D, Li B, Phillips G, Liang X, Gerber H, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-893.
43. Ankoma-Sey V, Wang Y, Dai Z. Hypoxic: stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. HEPATOLOGY 2000;31:141-148.
44. Martinez-Hernandez A, Amenta P. The extracellular matrix in hepatic regeneration. FASEB J 1995;9:1401-1410.
45. Ankoma-Sey V, Matli M, Chang K, Lalazar A, Donner D, Wong L, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998;17:115-121.
46. Hioki O, Minemura M, Shimizu Y, Kasii Y, Nishimori H, Takahara T, et al. Expression and localization of basic fibroblast growth factor (bFGF) in the repair process of rat liver injury. J Hepatol 1996;24:217-224.
47. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde A, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003;237:530-535.
48. Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, et al. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 2002;160:613-620.
49. Su AI, Guidotti L, Pezacki J, Chisari F, Schultz P. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci USA 2002;99:11181-11186.
50. Babic AM, Kireeva M, Kolesnikova T. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998;95:6355-6360.
51. Babic AM, Chen C, Lau L. Fisp 12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999;19:2958-2966.
52. Kim TH, Mars M, Stolz D, Petersen B, Michalopoulos G. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. HEPATOLOGY 1997;26:896-904.
53. Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr M, Sedlaczek N, et al. Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. HEPATOLOGY 1999;30:1159-1166.
54. Kim TH, Mars W, Stolz D, Michalopoulos G. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. HEPATOLOGY 2000;31:75-82.
55. Knirtel T, Mehde M, Grundmann A, Saile B, Scharf J, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 2000;113:443-453.
56. Nomura K, Miyagawa S, Ayukawa K, Soeda J, Taniguchi S, Kawasaki S. Inhibition of urokinase-type plasminogen activator delays expression of c-jun, activated transforming growth factor beta 1, and matrix metalloproteinase 2 during post-hepatectomy liver regeneration in mice. J Hepatol 2002;36:637-644.
57. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 1996;10:413-427.
58. Webber EM, Bruix J, Pierce R, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. HEPATOLOGY 1998;5:1226-1234.
59. Li W, Liang X, Leu J, Kovalovich K, Ciliberto G, Taub R. Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. HEPATOLOGY 2001;33:1377-1386.
60. Sakuda S, Tamura S, Yamada A, Miyagawa J, Yamamoto K, Kiso S, et al. Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats. J Hepatol 2002;36:378-384.
61. Friedman SL, Maher J, Bissell D. Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference. HEPATOLOGY 2000;32:1403-1408.
62. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995;108:231-241.
63. Wang YQ, Ikeda K, Ikebe T, Hirakawa K, Sowa M, Nakatani K, et al. Inhibition of hepatic stellate cell proliferation and activation by the semi-synthetic analogue of fumagillin TNP-470 in rats. HEPATOLOGY 2000;32:980-989.
64. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin D, et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 2003;52:1347-1354.
65. Yoshiji H, Kuriyama S, Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002;23:348-356.
66. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000;275:26765-26771.
67. Masferrer JL, Leahy K, Koki A, Zweifel B, Settle S, Woerner B, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311.
68. Leahy KM, Ornberg R, Wang Y, Zweifel B, Koki A, Masferrer J. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002;62:625-631.
69. Subbaramaiah K, Dannenberg A. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003;24:96-102.
70. Williams CS, Mann M, DuBois R. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908-7916.
71. Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
72. Simpson KJ, Henderson N, Bone-Larson C, Lukacs N, Hogaboam C, Kunkel S. Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci (Lond) 2003;104:47-63.
73. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
74. Mazzanti R, Messerini L, Monsacchi L, Buzzelli G, Zignego A, Foschi M, et al. CVH induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. HEPATOLOGY 1997;25:229-234.
75. Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, et al. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol 2001;32:1363-1370.
76. Majano PL, Garcia-Monzon C, Lopez-Cabrera M, Lara-Pezzi E, Fernandez-Ruiz E, Garcia-Iglesias C, et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest 1998;101:1343-1352.
77. Majano P, Lara-Pezzi E, Lopez-Cabrera M, Apolinario A, Moreno-Otero R, Garcia-Monzon C. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation. HEPATOLOGY 2001;34:1218-1224.
78. Shimoda K, Mori M, Shibuta K, Banner B, Barnard G. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma. Int J Oncol 1999;14:353-359.
79. Okano JI, Shiota G, Kawasaki H. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver 1999;19:151-159.
80. Medina J, Caveda L, Sanz-Cameno P, Arroyo A, Martin-Vilchez S, Majano P, et al. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J Hepatol 2003;35:660-667.
81. Lara-Pezzi E, Roche S, Andrisani O, Sanchez-Madrid F, Lopez-Cabrera M. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 2001;20:3323-3331.
82. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999;4:915-924.
83. Garcia-Monzon C, Garcia-Buey L, Majano P, Moreno-Otero R. Integrins: structure, biological functions and relevance in viral chronic hepatitis. Eur J Clin Invest 1995;25:71-78.
84. Kiosses WB, Shattil S, Pampori N, Schwartz M. Rac recruits high-affinity integrin avb3 to lamellipodia in endothelial cell migration. Nat Cell Biol 2001;3:316-320.
85. Lichtinghagen R, Bahr M, Wehmeier M, Michels D, Haberkorn C, Arndt B, et al. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 2003;105:373-382.
86. Takahara T, Furui K, Yata Y, Jin B, Zhang L, Nambu S, et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. HEPATOLOGY 1997;26:1521-1529.
87. Lara-Pezzi E, Gomez-Gaviro M, Galvez B, Mira E, Iniguez M, Fresno M, et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 2002;110:1831-1838.
88. Bussolino F, DiRenzo M, Ziche M, Bocchietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell mobility and growth. J Cell Biol 1992;119:629-641.
89. Grant SD, Kleinman H, Goldberg I, Bhargava M, Nickoloff B, Kinsella J, et al. Scatter factor induces blood vessel formation in vivo. Proc Nad Acad Sci USA 1993;90:1937-1947.
90. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Isner J. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 1998;97:381-390.
91. Okajima A, Miyazawa K, Naitoh Y, Inoue K, Kitamura N. Induction of hepatocyte growth factor activator messenger RNA in the liver following tissue injury and acute inflammation. HEPATOLOGY 1997;25:97-102.
92. Ikura Y, Morimoto H, Ogami M, Jomura H, Ikeoka N, Sakurai M. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol 1997;32:496-501.
93. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone C, Gentilini A, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996;148:785-800.
94. Lindahl P, Hellstrom M, Kalen M, Betsholtz C. Endothelial perivascular cell signaling in vascular development: lessons from knockout mice. Curr Opin Lipidol 1998;9:407-411.
95. Rappaport AM, MacPhee P, Fisher M, Phillips M. The scarring of the liver acini (cirrhosis). Tridimensional and microcirculatory consideration. Virchows Arch A Pathol Anat Histopathol 1983;402:107-137.
96. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. HEPATOLOGY 1998;27:1554-1562.
97. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J, et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999;155:1065-1073.
98. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. HEPATOLOGY 2002;35:1010-1021.
99. Shackel NA, McGuinness P, Abbott C, Gorrell M, McCaughan G. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 2001;49:567-576.
100. Shackel NA, McGuinness P, Abbott CA, Gorrell M, McCaughan G. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002;160:641-654.
101. Washington K, Clavien P, Killenberg P. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis. Hum Pathol 1997;28:791-795.
102. Matsunaga Y, Terada T. Peribiliary capillary plexus around interlobular bile ducts in various chronic liver diseases: an immunohistochemical and morphometric study. Pathol Int 1999;49:869-873.
103. Medina J, Jones E, Garcia-Monzon C, Moreno-Otero R. Immunopathogenesis of cholestatic autoimmune liver diseases. Eur J Clin Invest 2001;31:64-71.
104. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque M, Martin-Vilchez S, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002;37:723-729.
105. Battista S, Bar F, Mengozzi G, Pollet C, Torchio M, Cavalli G, et al. Evidence of an increased nitric oxide production in primary biliary cirrhosis. Am J Gastroenterol 2001;96:869-875.
106. Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin M, Nakanuma Y. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis. J Pathol 2000;190:93-99.
107. Medina J, Garcia-Buey L, Moreno-Otero R. Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther 2003;17:1-16.
108. Sato N, Kamada T, Kawano S, Hayashi N, Kishida Y, Meren H, et al. Effect of acute and chronic ethanol consumption on hepatic tissue oxygen tension in rats. Pharmacol Biochem Behav 1983;18:443-447.
109. French SW, Benson N, Sun P. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. HEPATOLOGY 1984;4:912-917.
110. Arteel GE, Iimuro Y, Yin M, Raleigh J, Thurman R. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. HEPATOLOGY 1997;25:920-926.
111. Bardag-Gorce F, French B, Li J, Riley N, Yuan Q, Valinluck V, et al. The importance of cycling of blood alcohol levels in the pathogenesis of experimental alcoholic liver disease in rats. Gastroenterology 2002;123:325-335.
112. Sarphie G, D'Souza N, Thiel DV, Hill D, McClain C, Deaciuc I. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res 1997;21:1128-1136.
113. Nanji AA, Tahan S, Golding M, Khwaja S, Rahemtulla A, Lalani E. Role of transforming growth factor-[beta] 1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease. Am J Pathol 1996;148:739-747.
114. Pinzani M, Milani S, Grappone C, Weber FL Jr, Gentilini P, Abboud H. Expression of platelet-derived growth factor in a model of acute liver injury. HEPATOLOGY 1994;19:701-707.
115. Marsden ER, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson S, Evarts R. Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest 1992;67:427-433.
116. Hu Z, Evarts R, Fujio K, Marsden E, Thorgeirsson S. Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat. Cell Growth Differ 1995;6:1019-1025.
117. Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989;86:1558-1562.
118. Maher J. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest 1993;90:1284-1289.